BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26145707)

  • 1. Diverse packaging of TF into platelets.
    Ruf W
    Thromb Haemost; 2015 Aug; 114(3):445. PubMed ID: 26145707
    [No Abstract]   [Full Text] [Related]  

  • 2. Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation.
    Brambilla M; Facchinetti L; Canzano P; Rossetti L; Ferri N; Balduini A; Abbonante V; Boselli D; De Marco L; Di Minno MN; Toschi V; Corsini A; Tremoli E; Camera M
    Thromb Haemost; 2015 Aug; 114(3):579-92. PubMed ID: 26062685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tissue factor in platelets: why is it so troublesome?
    Østerud B; Bouchard BA
    Platelets; 2019; 30(8):957-961. PubMed ID: 31146606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease: Insights into Platelet Tissue Factor.
    Camera M; Toschi V; Brambilla M; Lettino M; Rossetti L; Canzano P; Di Minno A; Tremoli E
    Semin Thromb Hemost; 2015 Oct; 41(7):737-46. PubMed ID: 26408918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do methodological differences account for the current controversy on tissue factor expression in platelets?
    Brambilla M; Rossetti L; Zara C; Canzano P; Giesen PLA; Tremoli E; Camera M
    Platelets; 2018 Jun; 29(4):406-414. PubMed ID: 28643538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor storage, synthesis and function in normal and activated human platelets.
    Mezzano D; Matus V; Sáez CG; Pereira J; Panes O
    Thromb Res; 2008; 122 Suppl 1():S31-6. PubMed ID: 18691497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in thromboxane A2 synthesis by megakaryocytes and platelets.
    Wojenski CM; Schick PK
    J Lab Clin Med; 1991 Oct; 118(4):370-6. PubMed ID: 1940580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.
    Brambilla M; Camera M; Colnago D; Marenzi G; De Metrio M; Giesen PL; Balduini A; Veglia F; Gertow K; Biglioli P; Tremoli E
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):947-53. PubMed ID: 18292391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The origin of fibrinogen in megakaryocytes and blood platelets].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1993; 24(1):23-5. PubMed ID: 8488733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
    Gerotziafas GT; Depasse F; Chakroun T; Samama MM; Elalamy I
    Thromb Haemost; 2004 Mar; 91(3):531-7. PubMed ID: 14983229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor expression by monocytes: regulation and pathophysiological roles.
    Osterud B
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S9-14. PubMed ID: 9819023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of megakaryocytes and platelets.
    Penington DG; Streatfield K
    Ser Haematol; 1975; 8(1):22-48. PubMed ID: 48278
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor-V expression in platelets from human megakaryocytic culture.
    Giampaolo A; Vulcano F; Macioce G; Mattia G; Barca A; Milazzo L; Ciccarelli C; Hassan HJ
    Br J Haematol; 2005 Jan; 128(1):108-11. PubMed ID: 15606556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo defibrination results in markedly decreased amounts of fibrinogen in rat megakaryocytes and platelets.
    Handagama PJ; Shuman MA; Bainton DF
    Am J Pathol; 1990 Dec; 137(6):1393-9. PubMed ID: 2260627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor expression in blood cells.
    Østerud B
    Thromb Res; 2010 Apr; 125 Suppl 1():S31-4. PubMed ID: 20149415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets.
    Schwertz H; Tolley ND; Foulks JM; Denis MM; Risenmay BW; Buerke M; Tilley RE; Rondina MT; Harris EM; Kraiss LW; Mackman N; Zimmerman GA; Weyrich AS
    J Exp Med; 2006 Oct; 203(11):2433-40. PubMed ID: 17060476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction to a review series: megakaryocytes to platelets in health and disease.
    Parise LV
    Blood; 2016 Mar; 127(10):1215. PubMed ID: 26787732
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression.
    Steiner S; Seidinger D; Huber K; Kaun C; Minar E; Kopp CW
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1697-702. PubMed ID: 12869353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboplastin synthesis in endothelial cells.
    Galdal KS
    Haemostasis; 1984; 14(5):378-85. PubMed ID: 6532908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of alpha granules to the membrane systems of platelets and megakaryocytes.
    Zucker-Franklin D
    Blood Cells; 1989; 15(1):73-9. PubMed ID: 2930855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.